6 November 2026
Latham Advises on Lyell Immunopharma’s US$80 Million Private Placement
Advising firms
Deal team
4 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Matt Bush Lead | Latham & Watkins LLP | Partner | corporate | San Diego |
| Anthony Gostanian | Latham & Watkins LLP | Counsel | Not stated | Not stated |
| Sterling Swift | Latham & Watkins LLP | Associate | Not stated | Not stated |
| Maria Watters | Latham & Watkins LLP | Not stated | Not stated | Not stated |
1 more lawyer on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 80m (US$80 million)
- What the figure measures
- Issue size
- Client
- Latham & Watkins LLPUnderwriters
- Counterparties
- Lyell Immunopharma, Inc. (Issuer)
ARCH Venture Partners (Investor)
Adage Capital Management LP (Investor)
Caligan Partners LP (Investor)
RTW Investments (Investor)